Robert G. Mcneil

Robert G. Mcneil discloses dealings in Regen Biologics Inc to SEC (Form 4). Over a trading history stretching from 24 May 2006 to 14 April 2009, the count stands at 12 filings.

Purchases make up the whole of the open-market record (7 purchases, €3.1M). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 1 share grant and 3 option exercises. In 2009 alone, the filings show 6 purchases and no sales.

Half of the purchases are above €11k and half below.

The record was last updated on 20 April 2009 with an open-market purchase (€11k) in Regen Biologics Inc. The median gap between a trade and its publication by SEC (Form 4) is 5 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.